Lv3
226 积分 2025-04-17 加入
Olaparib maintenance therapy in patients with newly diagnosed advanced ovarian cancer and a BRCA1 and/or BRCA2 mutation: SOLO1 China cohort
16天前
已完结
Letermovir prophylaxis for cytomegalovirus in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation
1个月前
已完结
Impaired CMV-specific CD4+ T-cell reconstitution is associated with CMV infection after letermovir cessation
1个月前
已完结
Apalutamide and Overall Survival in Prostate Cancer
1个月前
已完结
Enzalutamide, apalutamide, or darolutamide: are apples or bananas best for patients?
1个月前
已完结
Real-world comparison of prostate-specific antigen (PSA) response among patients with metastatic castration-sensitive prostate cancer (mCSPC) treated with apalutamide (APA) or enzalutamide (ENZ)
1个月前
已完结
KDIGO CKD–MBD guideline update: evolution in the face of uncertainty
1个月前
已完结
Recommendations from the 10th European Conference on Infections in Leukaemia for the management of cytomegalovirus in patients after allogeneic haematopoietic cell transplantation and other T-cell-engaging therapies
1个月前
已完结
Burosumab treatment for children younger than 12 months with X-linked hypophosphataemia
2个月前
已关闭
Emerging Role of Letermovir, a CMV DNA Terminase Inhibitor, in the Management of Cytomegalovirus Retinitis: Efficacy, Safety, and Treatment Outcomes
2个月前
已关闭
皖公网安备34019202002308
